Chenguang Biotech Group (300138) — Cash Flow Reinvestment Rate
Chenguang Biotech Group (300138) has a Cash Flow Reinvestment Rate of 0.07x as of September 2025, reinvesting CN¥37.63 Million (capex CN¥37.63 Million ) from operating cash flow of CN¥524.96 Million. Check 300138 cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Chenguang Biotech Group Cash Flow Reinvestment Rate (2008–2022)
Historical reinvestment intensity for Chenguang Biotech Group across 7 annual periods. Explore Chenguang Biotech Group long-term investment allocation to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Chenguang Biotech Group (2008–2022)
Year-by-year capital reinvestment analysis for Chenguang Biotech Group. For live market cap and broader valuation context, see 300138 company net worth.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 0.98x | CN¥716.94 Million | CN¥734.81 Million | CN¥176.03 Million | ▼ -92.4% |
| 2021 | 12.86x | CN¥821.73 Million | CN¥63.90 Million | CN¥280.82 Million | ▲ +1423.3% |
| 2020 | 0.84x | CN¥446.93 Million | CN¥529.41 Million | CN¥436.88 Million | ▲ +529.2% |
| 2014 | 0.13x | CN¥36.62 Million | CN¥272.96 Million | CN¥36.62 Million | ▼ -93.9% |
| 2011 | 2.21x | CN¥181.72 Million | CN¥82.18 Million | CN¥181.72 Million | ▼ -10.0% |
| 2009 | 2.46x | CN¥66.90 Million | CN¥27.23 Million | CN¥66.90 Million | ▼ -14.5% |
| 2008 | 2.87x | CN¥26.05 Million | CN¥9.06 Million | CN¥26.05 Million | — |